中山看痔疮需要多少钱中山屁眼周围长疙瘩,中山肛门中山华都医院好不好,中山大便出血看哪科,中山华都肛泰肛肠医院网,中山市华都肛肠医院可靠吗,中山什么肛肠医院比较好,中山肛瘘在哪里看

The US Department of Education has opened an investigation into the Ohio State University's handling of former students' allegations of sexual misconduct by a school doctor, according to the university.The federal investigation will be conducted by the department's Office for Civil Rights (OCR), which oversees Title IX complaints, the school said in a statement Thursday.The inquiry, led by the OCR's regional office in Cleveland, Ohio, "will examine whether the university is responding promptly and equitably to complaints and reports by former students," the statement said, "including allegations that employees knew or should have known about the sexual misconduct and allowed the abuse to continue."The scandal surrounding the alleged actions of the late Dr. Richard Strauss has grown since the university first announced in April its own investigation, headed by the law firm Perkins Coie, to look into claims made by male former athletes on 14 sports teams.Since then, more than 100 former Ohio State University students have reported firsthand accounts of sexual misconduct by Strauss, the school said last month.Some of them, mostly former student athletes, have come forward to publicly claim that Strauss sexually abused them under the guise of a medical examination.According to the school, the alleged abuse took place between 1979 and 1997."We welcome the involvement and careful oversight of OCR and look forward to providing any information we can," said Gates Garrity-Rokous, the school's vice president and chief compliance officer, in a statement about the US Department of Education's investigation."We responded promptly and appropriately to the allegations received in April about Dr. Strauss," Garrity-Rokous continued. "We are confident in the independence and thoroughness of the investigation we launched then as well as our ongoing commitment to transparency."The-CNN-Wire 1910

The Russian government denied Monday that it had interfered in the 2016 US election campaign in the Kremlin's first remarks since 13 Russian nationals were indicted Friday on charges of conspiring to defraud the US.Answering a question from CNN on a weekly telephone news conference, the spokesman for Russian President Vladimir Putin, Dmitry Peskov, said the indictments provided "no substantial evidence" of Russian meddling, and that there were "no indications that the Russian state could have been involved.""We didn't see any substantial evidence of someone interfering in the domestic affairs," Peskov added. He said the US indictment "mentions Russian citizens, but we heard the accusations against the Russian state -- that the Russian state, the Kremlin and the Russian government were involved."  820

The United States says they are delivering critical supplies to Lebanon after the deadly port explosion on Tuesday.The United States Air Force said in a press release that planes at the Al Udeid Air Base in Qatar were getting supplies out to help the Lebanon people after more than 100 people were killed in a deadly blast in Beirut.Officials said members of the 379th Air Expeditionary Wing, Air Mobility Command’s 8th Expeditionary Air Mobility Squadron and 816th Expeditionary Airlift Squadron on Al Udeid Air Base, and the Area Support Group-Qatar from Camp As Sayliyah helped in the delivery of the aid.“Support of this magnitude at such speed wouldn’t be possible without the joint effort of all members of Al Udeid Air Base, our U.S. Army counterparts at Camp As Sayliyah and our gracious Qatari partners,” said Brig. Gen. Daniel Tulley, 379th Air Expeditionary Wing commander in the statement. “In the wake of tragedy, it truly takes a combined effort to make the mission happen. We do this every day in Qatar, and that’s exactly what we are doing in support of the Lebanese Armed Forces.”Officials said 11 pallets, which contained more than 28,800 military field rations, 11,520 bottles of water, and two pallets of medical supplies were being delivered.According to the Associated Press, the blast killed at least 135 people and injured more than 5,000. 1371

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.Alongside the tablets, the agency also approved a diagnostic to detect the mutation."Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.Both treatments were granted Priority Review designation.Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review."A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.Both treatments also received?orphan drug?designation, a status granted to drugs for rare diseases or conditions. 2261

The victims' families and survivors of the Florida high school shooting have not held back, calling out the National Rifle Association in the days since the massacre.On Wednesday, Dana Loesch, the organization's national spokeswoman faced them for the first time.Loesch said the organization feels the process for buying firearms is flawed and ensured the audience that the NRA is fighting for them. But the crowd booed as she left the event.  456